Center for Endocrine Tumors

Overview

The Elizabeth and Michael Ruane Center for Endocrine Tumors at Massachusetts General Hospital Cancer Center is a comprehensive program specializing in the treatment of all types of benign and malignant endocrine tumors.

Although many endocrine conditions are benign (non-cancerous), our program combines the resources of the Massachusetts General Hospital Cancer Center and the Massachusetts General Hospital Division of Endocrinology to provide advanced treatment for all patients.

Learn more about our treatment programs for:

• Adrenal tumors
• Parathyroid tumors
• Thyroid tumors

Our Approach

Our program is one of the largest and most specialized in the country in treating disorders of the endocrine system. Among the innovations that make our program distinct are:

• Collaboration from a wide range of clinical experts, including endocrinologists, endocrine surgeons, oncologists, pathologists, radiologists, specialized nursing staff and a wide range of support services.
• Pioneering approaches to the treatment of endocrine disorders; from the first operation for hyperparathyroidism in 1926 to the most advanced diagnostics, procedures and medical therapies of today.
• Our endocrine surgeons' extensive, high volume surgical experience in the diseases of the thyroid, parathyroid and adrenal glands, including effective, minimally-invasive procedures.
• Advanced clinical trials to find better therapies for endocrine tumors.

Advanced Thyroid Cancer Center

The Massachusetts General Hospital–Massachusetts Eye and Ear Infirmary Advanced Thyroid Cancer Center provides unique multidisciplinary tertiary care for patients with advanced thyroid malignancy. Learn more about the Advanced Thyroid Cancer Center.